🇺🇸 FDA

Drug profile · INN

nilotinib

NILOTINIB ACCORD

approved L01EA03
US status
approved
Patents linked
4
News articles
0

Quick answer

nilotinib (NILOTINIB ACCORD) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN nilotinib
Brand NILOTINIB ACCORD
Formulation CAPSULE
ATC code L01EA03

Related patents

Search patents →

  1. US 10640487

    Solid state forms of Nilotinib salts

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9090598

    Nilotinib salts and crystalline forms thereof

    Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8937082

    Nilotinib salts and crystalline forms thereof

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8592442

    Nilotinib HCl crystalline forms

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is nilotinib?

nilotinib (NILOTINIB ACCORD) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for nilotinib?

NILOTINIB ACCORD is a marketed brand name for nilotinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of nilotinib?

nilotinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.